4//SEC Filing
Gregory Philip D 4
Accession 0001562180-23-000952
CIK 0001860782other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:59 PM ET
Size
8.8 KB
Accession
0001562180-23-000952
Insider Transaction Report
Form 4
Gregory Philip D
Chief Scientific Officer
Transactions
- Award
Common Stock
2023-02-01+142,857→ 267,375 total - Award
Common Stock
2023-02-01+25,000→ 124,518 total - Award
Stock Option (Right to buy)
2023-02-01+50,000→ 50,000 totalExercise: $13.20Exp: 2033-02-01→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]This restricted stock unit award vests over a four-year period at the rate of 25% on 01/01/2024, 25% on 01/01/2025, 25% on 01/01/2026, and 25% on 01/01/2027.
- [F2]This restricted stock unit award vests over a three-year period at the rate of 40% on 01/01/2024, 40% on 01/01/2025, and 20% on 01/01/2026.
- [F3]This stock option vests over a four-year period at the rate of 25% on 01/01/2024, and then in 36 equal monthly installments thereafter.
Documents
Issuer
2seventy bio, Inc.
CIK 0001860782
Entity typeother
Related Parties
1- filerCIK 0001343543
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:59 PM ET
- Size
- 8.8 KB